SLXN Silexion Therapeutics Corp Ordinary Shares BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) Best Biotech Stocks 2026 →

SLXN Stock Analysis: Buy, Sell, or Hold?

$2.66
-0.57 (-17.65%) β–Ό
5d: +1749.79% 30d: +1455.56% 90d: +533.03%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
26/100
Position
OVERSOLD
30-Day Fair Range
$0.14 – $0.23
Position: OVERSOLD
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$120.00
+4411.3% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.11 / $3.89
Trend: Strong Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: SLXN is 1056.5% above its trading range ($0.23). While momentum could continue, risk/reward favors waiting for a pullback.

Get Alerted When SLXN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: SLXN is currently trading at $2.66, which is considered oversold relative to its 30-day fair value range of $0.14 to $0.23.

Technical Outlook: Technically, SLXN is in a strong downtrend. Immediate support is located at $0.11, while resistance sits at $3.89. Short-term momentum is weak, with the stock down 17.6% recently.

Market Sentiment: SLXN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $120.00 (+4411.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.14 - $0.23
Company Quality Score 26/100 (SELL)
Volume Confirmation HIGH
Confidence Score 52.6%

Trading Range & Key Levels

30-Day Trading Range $0.14 - $0.23
Current vs Trading Range OVERSOLD
Support Level $0.11
Resistance Level $3.89
Current Trend Strong Downtrend
Technical data as of Nov 12, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (15/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-17.6%)
  • BULLISH: Trading 4411.3% below Wall St target ($120.00)
  • WARNING: Composite score 26/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -0.06
Wall Street Target $120.00 (+4411.3%)
Share SLXN Analysis

Share this live SLXN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (SLXN)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment is strong on StockTwits for $SLXN following a mention of $SLXN by a bullish trader along with the ticker symbol ADRX.
Key Retail Themes: Bullish sentiment Trader mention
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:59 PM ET
Data refreshes hourly during market hours. Next update: 8:59 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for SLXN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BMRN
Biomarin Pharmaceutical …
STRONG BUY
28 analysts
$91 53 HOLD
AXSM
Axsome Therapeutics Inc
STRONG BUY
22 analysts
$266 55 HOLD
DNLI
Denali Therapeutics Inc
STRONG BUY
20 analysts
$36 52 HOLD
INCY
Incyte Corporation
HOLD
28 analysts
$132 50 HOLD
RAPP
Rapport Therapeutics, In…
STRONG BUY
16 analysts
$64 48 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive SLXN Research Pages
SLXN Technical Chart SLXN Price Prediction SLXN Intrinsic Value DCF SLXN Earnings Date SLXN Investment Advisor SLXN Fair Price Analyzer SLXN Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals